Loading…
| # | Company | Offered Item | Amount | Rank | Status |
|---|---|---|---|---|---|
| 1 | L1₹20,823Qualified Item Categories: Anti TB Drugs - Pyrazinamide 750mg Dispersible Tablet 2 OFFICE NO 2B II CITI MALL BUILDING NO 03 LINK ROAD ANDHERI WEST MUMBAI SUBURBAN MAHARASTRA MUMBAI MAHARASHTRA 400053 | MUMBAI SUBURBAN | MAHARASHTRA | 400053 | Item Categories: Anti TB Drugs - Pyrazinamide 750mg Dispersible Tablet | L1 | Qualified MSE, Category: General |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
11 Aug 2023, 4:00 pmClosed
Anti TB Drugs - Pyrazinamide 750mg Dispersible Tablet (Q1)
5115397
GEM/2023/B/3768758
Single Packet Bid
Anti TB Drugs - Pyrazinamide 750mg Dispersible Tablet
GeM Contract
45 days
Uttar Pradesh; Muzaffarnagar
Total value wise evaluation
PRODUCT
Awarded to HEALTHY LIFE PHARMA PRIVATE LIMITED
₹20,823
| Product | Brand / Model | HSN | Quantity | Unit Price | Amount |
|---|---|---|---|---|---|
| Unbranded--HEALTHY LIFE PHARMA PRIVATE LIMITED Pyrazinamide 750mg Tablet | Unbranded--HEALTHY LIFE PHARMA PRIVATE LIMITED / PYRIZ-750 | 3004 | 660 strip | 31.55 | 20,823 |
| Item | Delivery Location | Qty | Delivery |
|---|---|---|---|
| Anti TB Drugs - Pyrazinamide 750mg Dispersible Tablet (Q1) | Manoj Kumar Tyagi 251001,DISTRICT TB HOSPITAL ,CMO OFFICE CAMPUS, NEAR PALDHARAMSHALLA, ROORKEE ROAD, MUZAFFARNAGAR | 660 | 45 days |
Exempted
14 Aug 2023
1 Aug 2023
11 Aug 2023
contract_GEMC-511687760169859.pdf
GEM_CONTRACT • 0.08 MB
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_5115397.pdf
GEM_BID
pyrazinamide-750mg-pc-23-updated-feb-2021_2022-04-13-15-57-56_6b569e05609ec1355654ad81b2423635.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .